The meeting is nothing more than a photo to disguise the problems they are all having at home. There’s nothing wrong with leaders meeting for coffee but everyone knows there is nothing of substance coming out of this. Trump believes the.
meet & greet is “substantive” but that’s ok —- as he avoids licking the biggest loss since Watergate for Republicans (!) for his absolutely inane “decision making “. Nice having him out of the country— he doesn’t have to be around for his Administration to screw up on a daily basis.
No meeting Trump has ever had with Putin has ever solved a problem.
Hoping this upcoming one will be different.
1
142
$AZN AstraZeneca gets Jefferies backing as broker sees $80 billion sales target within reach tinyurl.com/23rwb666 #AZN
184
$RYTM $VKTX $LLY - Rythm Pharmaceuticals gains on report Eli Lilly made $150/share offer with CVR - Betaville
Also reporting that LLY again looking at $VKTX
seekingalpha.com/news/467378…
2
420
Anthropic’s New IPO Filing Shows Amazon, Google Will Own Over A Quarter Of The Claude Maker $AMZN $GOOGL
stocktwits.com/news-articles….
121
$AZN - AstraZeneca Receives Two U.S. FDA Approvals, Including Expanded Use of Imfinzi and a New Treatment for a Rare Disease
147
Tim Carmichael retweeted
Less than a year ago, DOGE cut 400 jobs at the already understaffed FAA. At the time, FAA employees said the cuts would "have long-term safety implications." Looks like they were right. apnews.com/article/faa-firin…
$TGTX next meaningful stock trigger —- BRIUMVI SubQ data readout —- is just around the corner. This data could lead to higher revenue targets and blast the 30 million shares SOLD SHORT into covering their $$ losing negative bets🚀🚀🚀
$TGTX OW -JP catch up MGT -comments on next meaningful leg of BRIUMVI story -SUBq on track readout YE/early next year - trial has passed time points to collect 6 month PK endpoint for all 360 patients - data cleaning underway
$QURE high risk/ high reward — nothing available to patients with the deadly Huntingtons Disease. Risk/reward could be very positive over the next 6 months💥💥💥
Mr. Diamantas, the FDA Commissioner, literally telling you the vibes at the FDA. If you don't think $QURE isn't getting approved you've lost the plot.
5
824
CRWV Stock Eyes Biggest One-Day Gain Since August — Citi Sees Over 200% Upside After Q3 Beat
stocktwits.com/news-articles… $CRWV
94
$TGTX new 52 week high — 30 million shares SOLD SHORT. Must be getting a little hot under the collar betting that the strong fundamentals & technicals are going away🔥🔥🔥🔥🔥
TG Therapeutics’ CEO Sees Global Revenue Exceeding $1B In 2026 – BRIUMVI Drives Q3 Topline Beat
stocktwits.com/news-articles… $TGTX
1
21
652
$TGTX Jeffries like the story — PT $83
$TGTX Jefferies PT $83 SUBq on track &Commercial trends remain strong, w/ new pt starts accelerating exiting 3Q &into 4Q, Oct marking a record month for total Briumvi prescribers, and persistence remaining above Co's expectations. Tx-naive pts now represent ~40% of new pt starts vs. ~25% at launch, while ~1/3 of starts come from pts switching from another CD20. Co also highlighted increasing adoption among younger women aged 18-40, likely driven by increase in new starts. Hospital penetration is improving, w/ Sept and Oct representing strongest hospital months since launch.
13
395
CRWV Rallies Ahead Of Quarterly Report: Wells Fargo Calls CoreWeave ‘Highest Quality’ Firm Among Neocloud Peers, Sees Upside
stocktwits.com/news-articles…. $CRWV
135
TG Therapeutics’ CEO Sees Global Revenue Exceeding $1B In 2026 – BRIUMVI Drives Q3 Topline Beat
stocktwits.com/news-articles… $TGTX
META, AMZN Stocks Jump As JPMorgan Picks Pair Over Alphabet — Sees Stronger AI Returns, Cloud Growth
stocktwits.com/news-articles… $AMZN $META
1
159
SPCX Stock Rises As SpaceX Advances $24B Texas Data Center And Gas Plant Plans
stocktwits.com/news-articles… $SPCX
168
$TGTX
Having been invested in $TGTX for the last 5 years I’ve seen how people get too anxious around Q earnings announcements. Having such a large short position —all with $ losing positions— and jittery retail traders looking for takeovers will do that.
The shorts did their best to drill the stock down to the low $50s and failed — as institutional investors added to positions cleaning out the shaky sellers.
$TGTX continues to be in an enviable position, raising revenue and earnings estimates — as they continue to take market share Q after Q.
The story remains very much on track and looks to be a favorable risk/reward from current levels. Look for new highs. 💥💥💥💥










